Opthea (OPT) Revenue & Revenue Breakdown
Opthea Revenue Highlights
Latest Revenue (Y)
$108.41K
Latest Revenue (Q)
$61.27K
Opthea Revenue by Period
Opthea Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-06-30 | $108.41K | 19.54% |
| 2022-06-30 | $90.68K | 32.17% |
| 2021-06-30 | $68.61K | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2009-06-30 | - | -100.00% |
| 2008-06-30 | $14.35K | -24.98% |
| 2007-06-30 | $19.13K | 100.00% |
| 2006-06-30 | - | -100.00% |
| 2005-06-30 | $13.34K | 9.06% |
| 2004-06-30 | $12.24K | 100.00% |
| 2003-06-30 | - | -100.00% |
| 2002-06-30 | $9.57K | 100.00% |
| 2001-06-30 | - | 100.00% |
| 2000-06-30 | - | -100.00% |
| 1999-06-30 | $2.94B | 1524696.35% |
| 1998-06-30 | $192.74K | -19.86% |
| 1997-06-30 | $240.51K | 100.00% |
| 1996-06-30 | - | 100.00% |
| 1995-06-30 | - | 100.00% |
| 1994-06-30 | - | 100.00% |
| 1993-06-30 | - | - |
Opthea generated $108.41K in revenue during NA 2023, up 19.54% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Opthea Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $61.27K | 9.67% |
| 2023-06-30 | $55.87K | -60.31% |
| 2023-03-31 | $140.76K | 170.49% |
| 2022-12-31 | $52.04K | -66.22% |
| 2022-09-30 | $154.06K | 237.59% |
| 2022-06-30 | $45.63K | 49.67% |
| 2022-03-31 | $30.49K | -71.11% |
| 2021-12-31 | $105.54K | -0.54% |
| 2021-09-30 | $106.12K | -199.15% |
| 2021-06-30 | $-107.03K | 1.30% |
| 2021-03-31 | $-105.66K | -160.07% |
| 2020-12-31 | $175.90K | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2020-06-30 | $72.59K | 100.00% |
| 2020-03-30 | - | 100.00% |
| 2020-01-30 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-30 | - | -100.00% |
| 2018-12-31 | $45.96K | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-30 | - | -100.00% |
| 2017-12-31 | $24.71K | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-30 | - | 100.00% |
| 2017-01-30 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-30 | - | 100.00% |
| 2016-01-30 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-30 | - | 100.00% |
| 2015-01-30 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-30 | - | 100.00% |
| 2014-01-30 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-30 | - | 100.00% |
| 2013-01-30 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-30 | - | 100.00% |
| 2012-01-30 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-30 | - | 100.00% |
| 2011-01-30 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-30 | - | 100.00% |
| 2010-01-30 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-30 | - | 100.00% |
| 2009-01-30 | - | -100.00% |
| 2008-09-30 | $2.89K | 100.00% |
| 2008-06-30 | - | -100.00% |
| 2008-03-30 | $3.44K | 2.02% |
| 2008-01-30 | $3.37K | -32.27% |
| 2007-09-30 | $4.98K | 100.00% |
| 2007-06-30 | - | -100.00% |
| 2007-03-30 | $5.64K | - |
| 2007-01-30 | $5.64K | 100.00% |
| 2006-09-30 | - | 100.00% |
| 2006-06-30 | - | 100.00% |
| 2006-03-30 | - | 100.00% |
| 2006-01-30 | - | -100.00% |
| 2005-09-30 | $4.38K | - |
Opthea generated $61.27K in revenue during Q2 2024, up 9.67% compared to the previous quarter, and up 134.27% compared to the same period a year ago.
Opthea Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ADAG | Adagene | $18.11M | $833.34K |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| INBX | Inhibrx | $1.80M | - |
| MNOV | MediciNova | $1.00M | - |
| OPT | Opthea | $108.41K | $61.27K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| ANTX | AN2 Therapeutics | - | - |
| AVTE | Aerovate Therapeutics | - | - |
| CYT | Cyteir Therapeutics | - | - |
| ELYM | Eliem Therapeutics | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| CSBR | Champions Oncology | - | $12.02M |
OPT Revenue FAQ
What is Opthea’s yearly revenue?
Opthea's yearly revenue for 2023 was $108.41K, representing an increase of 19.54% compared to 2022. The company's yearly revenue for 2022 was $90.68K, representing an increase of 32.17% compared to 2021. OPT's yearly revenue for 2021 was $68.61K, representing an increase of 100.00% compared to 2020.
What is Opthea’s quarterly revenue?
Opthea's quarterly revenue for Q2 2024 was $61.27K, a 9.67% increase from the previous quarter (Q4 2023), and a -60.23% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $55.87K, a -60.31% decrease from the previous quarter (Q3 2023), and a 22.43% increase year-over-year (Q4 2022). OPT's quarterly revenue for Q3 2023 was $140.76K, a 170.49% increase from the previous quarter (Q2 2023), and a 361.64% increase year-over-year (Q3 2022).
What is Opthea’s revenue growth rate?
Opthea's revenue growth rate for the last 3 years (2021-2023) was 58.00%, and for the last 5 years (2019-2023) was 0%.